The new tools are offered on Bina's high-performance on-premises genomic analysis platform
April 21, 2014 04:39 PM Eastern Daylight Time
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Bina Technologies, the standard for high-performance genomic analysis, today announced a distribution agreement with Appistry, Inc., which enables Bina to include runtime licenses for the Genome Analysis Toolkit (GATK) and Cancer Genome Analysis (CGA) Suite NGS analysis tools as integral parts of the Bina Analytics genomics platform. Effective immediately, all of Bina's on-premises genomic analysis solutions, including both Bina Enterprise and Bina Desktop products, will integrate the GATK and CGA Suite, including MuTect for cancer genome analysis, into the Bina Analytics pipeline.
"By integrating the GATK and the CGA Suite into the Bina Analytics pipeline, we can offer a fully-supported solution for NGS data analysis that meets the performance needs and privacy requirements of our customers, and supports our ultimate mission -- to accelerate personalized medicine."
These widely accepted and highly-published software tools were originally developed by the Genome Sequencing and Analysis Group at the Broad Institute. Since its initial development, the GATK has proven itself the industry standard for analysis of human exome and whole genome datasets. The CGA Suite, only available from Appistry, includes several Broad-built tools for somatic mutation analysis, including MuTect, ContEst (for estimating contamination in datasets), and Somatic Indel Detector. Using these tools, researchers have identified new diseases markers, diagnosed children with rare genetic diseases, and made discoveries having to do with the identification and treatment of certain types of cancers, among many more.
When integrated into the Bina Analytics pipeline, the speed and throughput of the tools are greatly accelerated by Bina's proprietary, parallel computational technologies.
"Bina has significant experience with these world-class genomic tools and we will move forward quickly to place them in the hands of our end-users," said Dr. Narges Bani-Asadi, CEO of Bina Technologies. "By integrating the GATK and the CGA Suite into the Bina Analytics pipeline, we can offer a fully-supported solution for NGS data analysis that meets the performance needs and privacy requirements of our customers, and supports our ultimate mission -- to accelerate personalized medicine."
"As the Broad Institute's software commercialization partner, Appistry supports all efforts to get the GATK and the CGA Suite into the hands of more scientists to drive genomics research," said Trevor Heritage, Vice President of Corporate Development and Strategy at Appistry. "This agreement will enable Bina's customers to benefit from these industry-standard tools for NGS analysis."
To learn more about Bina Technologies' products and services, please visit: http://binatechnologies.com.
About Bina Technologies
Bina Technologies is the standard for high-performance genomic analysis. Our integrated hardware and software platforms provide workflows for the analysis and interpretation of complex genomic data sets, dramatically reducing time and cost.
Our fast, accurate, and scalable solutions empower clinical and academic researchers to concentrate on the science of personalized medicine, without getting bogged down in the data.
We are an interdisciplinary team of engineers, computer scientists, bioinformaticians and computational biologists revolutionizing human health and genomics research.
We are based in Redwood City, California. To learn more, visit: http://binatechnologies.com.
Contacts
for Bina Technologies
Brittany Smith, 972-809-6832
[email protected]